Patent · US Active

Ciprofloxacin polymorph and its use

US11104663B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

CRITITECH, INC. · US

Inventors

Mark Williams · Richland, US
Jacob SITTENAUER · Lawrence, US
Shelby CLARK · Lawrence, US
Joseph FARTHING · Lawrence, US
Michael Baltezor · Lee's Summit, US
Matthew McClorey · Lawrence, US

Key dates

Filing date	Sep 28, 2018
Grant date	Aug 31, 2021
Priority date	—
Expiry date	Sep 28, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to ciprofloxacin polymorphs and their use in treating infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.